Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 379-383, September 2006

Accrual issues in genitourinary cancer clinical trials☆

The University of California Davis Cancer Center, Sacramento, CA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This work was supported by R21 CA02501 (P.N.L.), American Cancer Society CRTG 0019701CCE (P.N.L.), NO1CM17101.

PII: S1078-1439(05)00304-2

doi:10.1016/j.urolonc.2005.11.037

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 379-383, September 2006

Article Tools